Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $381.3700 (2.38%) ($373.5050 - $382.6900) on Wed. Mar. 8, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.99% (three month average) | RSI | 46 | Latest Price | $381.3700(2.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 0.7% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(61%) XLV(49%) XBI(44%) IVW(42%) QQQ(42%) | Factors Impacting REGN price | REGN will decline at least -0.995% in a week (0% probabilities). VIXM(-8%) UUP(-8%) TLT(-6%) TIP(-2%) IPO(-2%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.995% (StdDev 1.99%) | Hourly BBV | 0 () | Intraday Trend | 2.1% | | | |
|
5 Day Moving Average | $378.07(0.87%) | 10 Day Moving Average | $374.14(1.93%) | 20 Day Moving Average | $371.95(2.53%) | To recent high | -1.5% | To recent low | 11.9% | Market Cap | $40.436b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |